Dr.Wei Zeng is the chief representative in the USA of Sungen Biomedical. He gets his postdoctor at Stony Brook University and Memorial Sloan Kettering Cancer Center. He has extensive expertise in biotechnology commercialization, with a focus on cancer early detection and therapeutic drug development. He is experienced in business operations and management of biotech startups, including cross-border ventures.